Seema Shete

Seema Shete (Patel) is a Principal Scientist and Immuno-oncology Alliance Science Program Lead at LifeArc, with experience dating back to September 2017. In this role, Seema leads multiple Immuno-oncology projects in collaboration with CRUK-TDL and Ono Pharma, focusing on the generation of antibodies against single and multi-transmembrane proteins. Previously, Seema served as a Senior Scientist and Lead Scientist for antibody humanization at MRC Technology, contributing expertise in antibody and protein modeling, protein engineering, and binding studies. Seema's career began as a Research Scientist at Isogenica Ltd, developing molecular display methodologies, and included a PhD in Biochemistry focused on cancer research from King's College London, supported by the Association of International Cancer Research. Education includes a BSc (Hons) in Molecular Biology and Genetics from Royal Holloway, University of London.